SynthesisThe Cochrane database of systematic reviews2026
Visual tubal patency tests for tubal occlusion and hydrosalpinx.
Synthesis in The Cochrane database of systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAround 18% to 33% of couples with infertility present with tubal occlusion (blocked or damaged fallopian tubes) or hydrosalpinx (fluid-filled tubes). Diagnostic laparoscopy (keyhole surgery) with chromopertubation (methylene blue dye tubal patency testing) is considered the reference standard for ruling out tubal occlusion and hydrosalpinx. However, due to its invasiveness and high costs, alternative, less invasive tests have been carried out using imaging techniques. They include sono-hysterosalpingography (sono-HSG), hysterosalpingography (HSG), outpatient transvaginal hydrolaparoscopy (THL), and magnetic resonance hysterosalpingography (MR-HSG). The choice of test varies in different settings; the choice of contrast, operator skill and test technology are factors that can influence diagnostic quality. Furthermore, the performance of the visual tubal patency tests can vary in different populations, depending on whether the test is carried out in an unselected group or in one classified as high or low risk for having tubal pathology.
objectivesTo determine and compare the diagnostic accuracy of visual tubal patency tests (sono-HSG, HSG, THL, and MR-HSG) for the diagnosis of tubal occlusion. Secondary objectives are to determine and compare the diagnostic accuracy of visual tubal patency tests (sono-HSG, HSG, THL, and MR-HSG) for the diagnosis of hydrosalpinx and to evaluate heterogeneity concerning population characteristics (population risk stratification) and index test characteristics (contrast media, technology, operator skills). SEARCH
methodsWe searched CENTRAL, MEDLINE, Embase and CINAHL, and two trials registers. We also contacted experts in the field for any additional studies (last date of search: 6 November 2023). SELECTION CRITERIA: We included studies on the diagnostic accuracy of a single index test and studies on the comparative diagnostic accuracy of two or more index tests. Index tests included were: sono-HSG, HSG, THL, and MR-HSG. Laparoscopy with methylene blue dye tubal patency testing was the reference standard. We included participants who had been trying to conceive for at least one year. All participants in the included studies should have undergone this reference standard. Target conditions were bilateral tubal occlusion, at least one-sided tubal occlusion, tubal occlusion by tube, and hydrosalpinx. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data. We performed random-effects meta-analysis in a bivariate model. For each index test, we presented pairs of sensitivity and specificity with their 95% confidence intervals (CIs) for each study, as well as the pooled sensitivity and specificity in a forest plot. We used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 tool for risk of bias assessments. MAIN
resultsWe identified 11,787 records and included 21 studies (1939 participants). Two studies directly compared both sono-HSG and HSG to the reference test, while the other 19 reported on the diagnostic accuracy of one of the index tests (10 on sono-HSG, 10 on HSG, and 3 on THL). We did not include any studies of MR-HSG. Sono-HSG: for bilateral tubal occlusion, the pooled sensitivity was 0.98 (95% CI 0.19 to 1.00; 3 studies, 259 women; moderate-certainty evidence) and specificity was 0.99 (95% CI 0.93 to 1.00; 4 studies, 259 women; high-certainty evidence). Subgroup analyses showed that colour Doppler was associated with higher specificity than standard ultrasound, but with similar sensitivity. We did not find differences in diagnostic accuracy in the use of 3-dimensional/2-dimensional or 2-dimensional ultrasound, or the use of foam or saline as contrast media. We were unable to perform meta-analysis on the diagnosis of hydrosalpinx. HSG: for bilateral tubal occlusion, the pooled sensitivity was 0.77 (95% CI 0.58 to 0.89; 7 studies, 670 women; very low-certainty evidence) and the pooled specificity was 0.94 (95% CI 0.87to 0.97; 7 studies, 670 women; moderate-certainty evidence). For hydrosalpinx by tube, the pooled sensitivity was 1.00 and specificity was 0.96 (95% CI 0.96 to 0.98; 2 studies, 360 tubes). THL: for bilateral tubal occlusion, the pooled sensitivity and specificity were 0.95 (95% CI 0.30 to 1.00; 3 studies, 172 women; low-certainty evidence) and 0.99 (95% CI 0.84 to 1.00; 3 studies, 172 women; moderate-certainty evidence), respectively. We were unable to perform meta-analysis on the diagnosis of hydrosalpinx. There was insufficient information on operator skills and patient risk stratification for all index tests to carry out further analyses. AUTHORS'
conclusionsThe evidence showed that sono-HSG, HSG and THL are all reliable tests for the diagnosis of double-sided tubal occlusion. Evidence for comparative diagnostic accuracy studies is very limited. We did not include any studies on the diagnostic accuracy of MR-HSG. The certainty of evidence ranged from very low to high. This was mainly due to unclear or high risk of bias, heterogeneity and imprecision. Limited reporting on population risk and operator experience may reduce the generalisability of the findings to routine clinical practice.
fundingThis Cochrane review had no dedicated funding. REGISTRATION: Protocol (2022) available via: https://doi.org/10.1002/14651858.CD014968.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.